Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Proven Peptides was a prominent US-based online retailer specializing in Selective Androgen Receptor Modulators (SARMs) and research peptides. The company established a strong reputation within the biohacking and fitness communities by offering third-party laboratory verification for every product batch, ensuring high purity and concentration. Their product line featured popular experimental compounds such as Ostarine, Ligandrol, and Ibutamoren, marketed strictly for laboratory research use. In November 2020, Proven Peptides ceased all operations, citing the increasingly restrictive regulatory environment and potential legislative bans on SARMs. While not a traditional drug development firm with a clinical pipeline, the company was a significant player in the distribution of life science research chemicals.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Proven Peptides.